MICHELLE KNODELL: Open Payments
NPI 1417603366 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,560 in 74 payments from 20 companies in 2025. Trend: 2023 $1,462 · 2024 $1,511 · 2025 $1,560
Food & beverage: $1,560
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 12 | $239 |
| Amgen Inc. | 12 | $220 |
| UCB, Inc. | 6 | $178 |
| ABBVIE INC. | 10 | $157 |
| Fresenius Kabi USA, LLC | 5 | $123 |
| PFIZER INC. | 4 | $111 |
| Janssen Biotech, Inc. | 2 | $72 |
| Mallinckrodt Hospital Products Inc. | 3 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $51 |
Products named: PURIFIED CORTROPHIN GEL, Bimzelx, Otezla, XELJANZ, REXULTI, VRAYLAR, TREMFYA, RINVOQ.
Industry payments across TX — which companies pay providers there.
